Annovis files three new patents for Buntanetap combinations with Trulicity and Viagra

Annovis Bio, Inc.

Patents cover Buntanetap + Trulicity (GLP-1), Buntanetap + Viagra (PDE5i), and triple combo.
Preclinical synergy data showed cognition in AD mouse models improved beyond healthy controls.
Combinations positioned for Phase 3 trials; Buntanetap completed Phase 3; Trulicity and Viagra are FDA-approved.
CEO: combination could restore and improve cognition, offering new hope in dementia fight.
Annovis expands IP portfolio for neurodegenerative disorders with these filings.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.